| AM | Atypical myopathy |
| C4 | Butyryl-/isobutyrylcarnitine |
| C4-OH | Hydroxy butyryl-/isobutyrylcarnitine |
| C4-DC | Succinyl-/methylmalonylcarnitine |
| C5 | Isovaleryl-/2-methylbutyrylcarnitine |
| C5:1 | Tiglycarnitine |
| C5-OH | Hydroxy isovalerylcarnitine |
| C5-DC | Glutarylcarnitine |
| C6 | Hexanoylcarnitine |
| C8 | Octanoylcarnitine |
| C10 | Decanoylcarnitine |
| DMSO | Dimethyl sulphoxide |
| N EC50 | Median effective concentration |
| HGA | Hypoglycin A |
| LC50 | Median lethal concentration |
| LC-MS | Liquid chromatography–mass spectrometry |
| MCPA | Methylenecyclopropylacetate |
| MCPA-CoA | Methylenecyclopropylacetyl-CoA |
| MCPrG | Methylenecyclopropylglycine |
| MS/MS | Tandem mass spectrometry |
| OECD | Organisation for Economic Co-operation and Development |
| RFT | Range finding test |
| zFET | Zebrafish embryo toxicity |